South Korean Fair Trade Commission Investigates Drug Makers For Offering Unethical Financial Incentives To Hospitals
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Fair Trade Commission is in the final stages of investigations into seven pharmaceutical companies including five foreign pharma companies in a series of complaints from civic groups that drug makers were offering financial incentives to hospitals and doctors to give priority to their products
You may also be interested in...
Korea’s Fair Trade Commission Catches Samil Pharm Again For Illegal Rebates
Despite continuing government efforts to weed out kickbacks from pharma to doctors and hospitals, stopping the illegal practice has proved difficult.
South Korean Government Moves To Suspend Pharmacists Accepting Rebates From Pharma Companies
SEOUL - In an unusually strong move, the South Korean government is moving to revise some of its pharmaceutical rules to punish pharmacists receiving rebates from pharmaceutical companies
South Korean Government Moves To Suspend Pharmacists Accepting Rebates From Pharma Companies
SEOUL - In an unusually strong move, the South Korean government is moving to revise some of its pharmaceutical rules to punish pharmacists receiving rebates from pharmaceutical companies